Cargando…
Phospholipase C delta 1 inhibits WNT/β‐catenin and EGFR-FAK-ERK signaling and is disrupted by promoter CpG methylation in renal cell carcinoma
BACKGROUND: PLCD1, located at 3p22, encodes an enzyme that mediates cellular metabolism and homeostasis, intracellular signal transduction and movement. PLCD1 plays a pivotal role in tumor suppression of several types of cancers; however, its expression and underlying molecular mechanisms in renal c...
Autores principales: | Xie, Jianlian, Zhou, Jun, Xia, Jiliang, Zeng, Ying, Huang, Guo, Zeng, Weihong, Fan, Tingyu, Li, Lili, Zeng, Xi, Tao, Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972803/ https://www.ncbi.nlm.nih.gov/pubmed/36849889 http://dx.doi.org/10.1186/s13148-023-01448-2 |
Ejemplares similares
-
Fundamental diversity of human CpG islands at multiple biological levels
por: Zeng, Jia, et al.
Publicado: (2014) -
Site-specific CpG methylation in the CCAAT/enhancer binding protein delta (CEBPδ) CpG island in breast cancer is associated with metastatic relapse
por: Palmieri, C, et al.
Publicado: (2012) -
Engineering CpG island DNA methylation in pluripotent cells through synthetic CpG-free ssDNA insertion
por: Tompkins, Joshua, et al.
Publicado: (2023) -
Preservation of methylated CpG dinucleotides in human CpG islands
por: Panchin, Alexander Y., et al.
Publicado: (2016) -
Suppressive CpG
por: Van Epps, Heather L.
Publicado: (2005)